Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shao-Guang Sun has a total of 133 co-authors. Here are the top co-authors by number of shared publications:

  • Si-Fan Wang

    Department of Biochemistry and Molecular Biology, Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Key Laboratory of Forensic Medicine, Hebei Medical University, Shijiazhuang, China (S.-F.W., L.-Y.Y., A.-Q.Z., Z.-Y.W., S.W., M.G., S.-G.S.).

    8 shared publications
  • Li-Yun Yang

    Department of Biochemistry and Molecular Biology, Key Laboratory of Medical Biotechnology of Hebei Province, Cardiovascular Medical Science Center, Hebei Medical University, Shijiazhuang 050017, China

    7 shared publications
  • Shuyan Yang

    Beijing Municipal Key Laboratory of Child Development and Nutriomics, Capital Institute of Pediatrics, Beijing, China

    7 shared publications
  • Miao Gong

    Department of Biochemistry and Molecular Biology, Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Key Laboratory of Forensic Medicine, Hebei Medical University, Shijiazhuang, China (S.-F.W., L.-Y.Y., A.-Q.Z., Z.-Y.W., S.W., M.G., S.-G.S.).

    6 shared publications
  • An-Qi Zhao

    Department of Biochemistry and Molecular Biology, Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Key Laboratory of Forensic Medicine, Hebei Medical University, Shijiazhuang, China (S.-F.W., L.-Y.Y., A.-Q.Z., Z.-Y.W., S.W., M.G., S.-G.S.).

    5 shared publications
  • Jia-Jie Lin

    Department of Biochemistry and Molecular Biology, Key Laboratory of Medical Biotechnology of Hebei Province, Cardiovascular Medical Science Center, Hebei Medical University, Shijiazhuang 050017, China

    5 shared publications

Latest Publications

  • Open Access

    tsRNA‐076 Promotes VSMC Autophagy and Vascular Remodeling by Activating IGF2BP2 Transcription

    by Shanhu Cao, Qian Zhang, Sifan Wang, Sen Wang, Qiao Tang, Zhaoyi Wang, Yuguang Cao, Ziqi Dong, Wenjun Luo, Liyun Yang, et al.

    TRNA‐derived small RNAs (tsRNAs) are an emerging class of regulatory non‐coding RNAs involved in diverse biological processes, yet their functions in the nucleus remain poorly understood. Here, we identify a nuclear‐enriched tsRNA, tsRNA‐076, that is markedly upregulated in synthetic vascular smooth muscle cells (VSMCs) and plays an important role in vascular remodeling. Mechanistically, tsRNA‐076 functions as an endogenous small activating RNA (saRNA) by directly associating with the IGF2BP2 (insulin‐like growth factor 2 mRNA binding protein 2) promoter and facilitating recruitment of the transcription factor ETV2 (ETS variant transcription factor 2), thereby driving transcriptional activation of IGF2BP2 . Elevated IGF2BP2 enhances ATG5 expression by stabilizing its mRNA in an m 6 A‐dependent manner, thereby promoting VSMC autophagy. Inhibition of tsRNA‐076 attenuates VSMC autophagy and alleviates vascular remodeling in vitro and in vivo. Together, these findings uncover a previously unrecognized RNA activation mechanism mediated by tsRNA‐076 and provide new insights into vascular remodeling.

  • A Novel Hidden Protein p-414aa Encoded by circSETD2(14,15 ) Inhibits Vascular Remodeling

    by Si-Fan Wang, Li-Yun Yang, An-Qi Zhao, Zhao-Yi Wang, Sen Wang, Miao Gong, Ming-Qi Zheng, Gang Liu, Shu-Yan Yang, Jia-Jie Lin, et al.

    BACKGROUND: Phenotypic switching of vascular smooth muscle cells (VSMCs), leading to neointimal hyperplasia, is a fundamental cause of vascular remodeling diseases such as atherosclerosis and hypertension. Novel hidden proteins encoded by circular RNAs play crucial roles in disease progression, yet their involvement in vascular remodeling diseases has not been comprehensively studied. This study identifies a novel protein derived from a circular RNA in VSMCs and demonstrates its potential role in regulating vascular remodeling. METHODS: Cell proliferation assays were performed to investigate the effects of circSETD2(14,15 ) on VSMC proliferation. Techniques such as vector construction, immunoprecipitation–mass spectrometry, and dual-luciferase reporter gene were used to confirm that circSETD2(14,15 ) encoded a novel protein, p-414aa. The interaction between p-414aa and HuR (human antigen R) was validated with techniques such as co-immunoprecipitation, mass spectrometry, and proximity ligation assay. Through experiments including RNA sequencing and RNA immunoprecipitation, the interaction between HuR and C-FOS (C-Fos proto-oncogene) mRNA was revealed. The role of p-414aa in neointimal hyperplasia was assessed with a carotid artery ligation model in male mice. RESULTS: Overexpression of circSETD2(14,15 ) inhibits VSMC phenotypic switching. The novel protein p-414aa, encoded by circSETD2(14,15 ), interacts with HuR to reduce C-FOS mRNA stability, thereby suppressing VSMC proliferation and ultimately inhibiting neointimal hyperplasia in male mice. CONCLUSIONS: We uncover a novel hidden protein derived from circSETD2(14,15 ), called p-414aa, that inhibits vascular remodeling. CircSETD2(14,15 ) and p-414aa may serve as potential therapeutic targets for vascular remodeling diseases.


  • Open Access

    Hsa_circ_0001304 promotes vascular neointimal hyperplasia accompanied by autophagy activation

    by Shi-Qing Mu, Jia-Jie Lin, Yu Wang, Li-Yun Yang, Sen Wang, Zhao-Yi Wang, An-Qi Zhao, Wen-Jun Luo, Zi-Qi Dong, Yu-Guang Cao, et al.

    Aberrant autophagy in vascular smooth muscle cells (VSMCs) is associated with the progression of vascular remodeling diseases caused by neointimal hyperplasia. Platelet-derived growth factor-BB (PDGF-BB)-induced vascular remodeling is accompanied by autophagy activation, however, the involvement of circular RNAs (circRNAs) remains unclear. Here, we show the role of PDGF-BB-regulated hsa_circ_0001304 (circ-1304) in neointimal hyperplasia and its potential involvement in VSMC autophagy, while also elucidating the potential mechanisms. Functionally, overexpression of circ-1304 promotes VSMC autophagy in vitro and exacerbates neointimal hyperplasia in vivo, and this exacerbation is accompanied by autophagy activation. Mechanistically, circ-1304 acts as a sponge for miR-636, resulting in increased protein levels of YTHDF2. Subsequently, the YTHDF2 protein promotes the degradation of mTOR mRNA by binding to the latter’s m6A modification sites. We demonstrate that PDGF-BB activates VSMC autophagy via circRNA regulation. Therefore, circ-1304 may serve as a potential therapeutic target for vascular remodeling diseases.


  • Open Access

    Hsa_circ_0001304 promotes vascular smooth muscle cell autophagy and neointimal hyperplasia through the YTHDF2/mTOR axis

    by Shi-Qing Mu, Jia-Jie Lin, Yu Wang, Li-Yun Yang, Sen Wang, Zhao-Yi Wang, An-Qi Zhao, Wen-Jun Luo, Zi-Qi Dong, Yu-Guang Cao, et al.

    Introduction Aberrant autophagy in vascular smooth muscle cells (VSMCs) is associated with the progression of cardiovascular diseases. Recently, circular RNAs (circRNAs) have gradually been reported to regulate autophagy in VSMCs. Objectives This study aims to investigate the role of hsa_circ_0001304 in VSMC autophagy and its underlying mechanism. Methods The combined use of dual-luciferase reporter gene assay, MeRIP-qRT-PCR, RIP-qRT-PCR, etc., was performed to verify the regulatory axis, hsa_circ_0001304/miR-636/YTHDF2/mTOR. Cell autophagy detection was performed to uncover the role of hsa_circ_0001304 on VSMC autophagy. The mouse carotid artery ligation model was conducted to assess the role of hsa_circ_0001304 on vascular neointimal hyperplasia. Results Hsa_circ_0001304 acts as a sponge for miR-636, leading to an increase in the protein levels of YTHDF2. Subsequently, the YTHDF2 promotes the degradation of mTOR mRNA by binding to the latter’s m6A modification sites. Thus, by regulating the miR-636/YTHDF2/mTOR axis, hsa_circ_0001304 activates VSMC autophagy, aggravating neointimal hyperplasia. Conclusion Our findings suggest that autophagy-related hsa_circ_0001304 could serve as a novel therapeutic target for neointimal hyperplasia-related cardiovascular diseases. Including spaces Our study documents a novel VSMC autophagy-related circRNA, namely circ-1304, which activates VSMC autophagy through the miR-636/YTHDF2/mTOR axis, thereby exacerbating neointimal hyperplasia. Targeting autophagy-related circ-1304 may contribute to the treatment of neointimal hyperplasia-associated cardiovascular diseases.

  • Open Access

    nkx2.3 is responsible for posterior pharyngeal cartilage formation by inhibiting Fgf signaling

    by Shuyan Yang, Xin Xu, Zheng Yin, Yuelin Liu, Handong Wang, Jin Guo, Fang Wang, Yihua Bao, Ting Zhang, Shaoguang Sun


  • Open Access

    adducin 1 is essential for the survival of erythroid precursors via regulating p53 transcription in zebrafish

    by Shuyan Yang, Shanhu Cao, Xuebing Xu, Quan Li, Jianting Li, Jin Guo, Fang Wang, Yihua Bao, Zean Jiang, Ting Zhang, et al.


  • Open Access

    Hsa_circ_0001402 alleviates vascular neointimal hyperplasia through a miR-183-5p-dependent regulation of vascular smooth muscle cell proliferation, migration, and autophagy

    by Jia-Jie Lin, Rui Chen, Li-Yun Yang, Miao Gong, Mei-Yang Du, Shi-Qing Mu, Ze-An Jiang, Huan-Huan Li, Yang Yang, Xing-Hui Wang, et al.


  • Open Access

    Integrated analysis of tRNA-derived small RNAs in proliferative human aortic smooth muscle cells

    by Jian-Zhi Zhao, Qi-Yao Li, Jia-Jie Lin, Li-Yun Yang, Mei-Yang Du, Yu Wang, Ke-Xin Liu, Ze-An Jiang, Huan-Huan Li, Si-Fan Wang, et al.

    Background: Abnormal proliferation of vascular smooth muscle cells (VSMCs) contributes to vascular remodeling diseases. Recently, it has been discovered that tRNA-derived small RNAs (tsRNAs), a new type of noncoding RNAs, are related to the proliferation and migration of VSMCs. tsRNAs regulate target gene expression through miRNA-like functions. This study aims to explore the potential of tsRNAs in human aortic smooth muscle cell (HASMC) proliferation. Methods: High-throughput sequencing was performed to analyze the tsRNA expression profile of proliferative and quiescent HASMCs. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to validate the sequence results and subcellular distribution of AS-tDR-001370, AS-tDR-000067, AS-tDR-009512, and AS-tDR-000076. Based on the microRNA-like functions of tsRNAs, we predicted target promoters and mRNAs and constructed tsRNA–promoter and tsRNA–mRNA interaction networks. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to reveal the function of target genes. EdU incorporation assay, Western blot, and dual-luciferase reporter gene assay were utilized to detect the effects of tsRNAs on HASMC proliferation. Results: Compared with quiescent HASMCs, there were 1838 differentially expressed tsRNAs in proliferative HASMCs, including 887 with increased expression (fold change > 2, p < 0.05) and 951 with decreased expression (fold change < ½, p < 0.05). AS-tDR-001370, AS-tDR-000067, AS-tDR-009512, and AS-tDR-000076 were increased in proliferative HASMCs and were mainly located in the nucleus. Bioinformatics analysis suggested that the four tsRNAs involved a variety of GO terms and pathways related to VSMC proliferation. AS-tDR-000067 promoted HASMC proliferation by suppressing p53 transcription in a promoter-targeted manner. AS-tDR-000076 accelerated HASMC proliferation by attenuating mitofusin 2 (MFN2) levels in a 3′-untranslated region (UTR)-targeted manner. Conclusions: During HASMC proliferation, the expression levels of many tsRNAs are altered. AS-tDR-000067 and AS-tDR-000076 act as new factors promoting VSMC proliferation.


  • Open Access

    LncRNA BIRF Promotes Brain Ischemic Tolerance Induced By Cerebral Ischemic Preconditioning Through Upregulating GLT-1 via Sponging miR-330-5p

    by Shichao Li, Lingyan Zhang, Jiajie Lin, Achou Su, Xiyun Liu, Jingge Zhang, Xiaohui Xian, Yuyan Hu, Wenbin Li, Shaoguang Sun, et al.

    Long noncoding RNAs (lncRNAs) play an important regulatory role in various diseases. However, the role of lncRNAs in brain ischemic tolerance (BIT) induced by cerebral ischemic preconditioning (CIPC) is still unknown. The lncRNA profile of rat cortical astrocytes pretreated with ischemic preconditioning was analyzed by high-throughput sequencing. The results of Cell-Counting Kit-8 (CCK-8) assay showed that a novel lncRNA, NONRATT009133.2, which we referred to as brain ischemia–related factor (BIRF), was highly correlated with BIT. Through bioinformatics analysis, we predicted that BIRF, miR-330-5p, and GLT-1 (also named Slc1a2) might constitute a ceRNA regulatory network in the induction of BIT. We found that BIRF was upregulated by CIPC, which promoted GLT-1 expression and BIT induction. BIRF could directly bind to miR-330-5p. Furthermore, miR-330-5p directly targeted GLT-1, and miR-330-5p inhibited both GLT-1 expression and BIT induction in vitro and in vivo. Moreover, BIRF acts as a molecular sponge to competitively bind to miR-330-5p with GLT-1 mRNA, while the miR-330-5p inhibitor reversed all the effects of BIRF siRNA on GLT-1 expression and neuronal vitality. Taken together, our results demonstrate the important roles of the BIRF/miR-330-5p/GLT-1 axis in the induction of BIT by CIPC. BIRF may be a potentially effective therapeutic strategy against stroke injury.